|
|
| 2.03 Data as of Apr 17 |  +0.01 / +0.49%Today’s Change | 1.55 Today|||52-Week Range 3.34 | -27.76% Year-to-Date |
| Update on BioLineRx's BL-8040 - Analyst Blog Apr 11 / Zacks.com |
| Previous close | 2.03 |
| Today’s open | 2.04 |
| Day’s range | 1.99 - 2.05 |
| Volume | 70,389 |
| Average volume (3 months) | 245,024 |
| Market cap | $73.7M |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| CBRXColumbia Laboratorie... | -0.04 | -0.59% |
| ALXAAlexza Pharmaceutica... | +0.03 | +0.73% |
| AVEOAveo Pharmaceuticals... | -0.05 | -3.60% |
| MSTXMast Therapeutics In... | +0.01 | +1.80% |
| Next reporting date | May 13, 2014 |
| EPS forecast (this quarter) | -$0.12 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | -- |
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters --, -- |
.
